Trz Series 40 mg is a research product associated with tirzepatide, a synthetic peptide that acts on GIP and GLP-1 receptors. These receptor pathways play important roles in glucose homeostasis, insulin secretion, and metabolic signalling.

Tirzepatide has attracted scientific interest because of its dual-receptor activity. Research into these pathways contributes to a broader understanding of the biological mechanisms involved in glucose regulation, appetite signalling, and energy metabolism.